Results 171 to 180 of about 177,236 (307)

Availability of behavioral health crisis care and associated changes in emergency department utilization

Health Services Research, Volume 60, Issue 2, April 2025.
Abstract Objective To determine whether availability of behavioral health crisis care services is associated with changes in emergency department (ED) utilization. Data Sources and Study Setting We used longitudinal panel data (2016–2021) on ED utilization from the Healthcare Cost and Utilization Project's State ED Databases and a novel dataset on ...
Ashlyn Burns, Joshua R. Vest, Nir Menachemi, Olena Mazurenko, Paul I. Musey Jr., Michelle P. Salyers, Valerie A. Yeager   +6 more
wiley   +1 more source

The role of harms and burdens in clinical practice guidelines: Lessons learned from the American Psychological Association's guideline development

Clinical Psychology: Science and Practice, EarlyView., 2020
Abstract Growing evidence supports the efficacy of various psychosocial interventions yet provides very little information about the potential harms and burdens of treatment. Lacking such information makes it difficult to make truly informed decisions about treatment options.
Raquel W. Halfond, Caroline Vaile Wright, Lynn F. Bufka   +2 more
wiley   +1 more source

Gambling disorder as a risk factor for suicidal ideation in medical students. [PDF]

Sci Rep
Luquiens A, Bourgier C, Fabbro-Peray P.
europepmc   +1 more source

Trajectories of Suicidal Risk Impact Mood Regulation Differently in Patients With a Diagnosis of Bipolar Disorder

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Background Bipolar disorder (BD) carries a suicide risk 20 times higher than the general population, with up to 60% of patients attempting suicide. Current interventions have failed to reduce its incidence; static factors have shown limited predictive utility.
Abigail Ortiz, Ramzi Halabi, Daniel Blumberger, Christina Gonzalez‐Torres, Arend Hintze, Muhammad I. Husain, Mirkamal Tolend, Juveria Zaheer, Martin Alda, Benoit H. Mulsant   +9 more
wiley   +1 more source

Global Prevalence and Risk Factors of Suicidal Ideation in Multiple Sclerosis: A Systematic Review and Meta-Analysis. [PDF]

Health Sci Rep
Bazmi E, Behnoush AH, Mohammadi Lapevandani M, Talebian MT, Jahani S, Sahraian MA.   +5 more
europepmc   +1 more source

Blood Alcohol Concentration in Finnish Suicide Deaths and Associated Risk Factors, 2016–2024

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Aims There is limited research examining the relationship between blood alcohol concentration (BAC) and other risk factors among suicide deaths in Finland. Our study aimed to investigate the relationship of an elevated (more than zero) blood alcohol concentration with medical history, including sociodemographic characteristics and disease ...
Tristan Pokornyi, Marjut Grainger, Timo Partonen   +2 more
wiley   +1 more source

Psychiatric comorbidity in DiGeorge association: Suicidal ideation and bipolar disorder. [PDF]

J Mood Anxiety Disord
Nakhamiyayev R, Perry M, Sood S, Kamboj S, Khodra E, Agada B.   +5 more
europepmc   +1 more source

Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial

Addiction, EarlyView.
Abstract Background and Aims Psilocybin has emerged as a potential treatment for alcohol use disorder (AUD), but early efficacy data are inconsistent. Depression following alcohol detoxification significantly increases the risk of relapse. This pilot study aimed to evaluate the feasibility, acceptability, and preliminary efficacy of psilocybin‐assisted
Amandine Luquiens, Dahbia Belahda, Carine Graux, Noe Igounenc, Chris Serrand, Paul Rochefort, Thibault Mura, Felix Sergent   +7 more
wiley   +1 more source

No Thesis, No Future! Exploring the associations between research inaccessibility and suicidal ideation. [PDF]

PLoS One
Huraira MA, Khan MM, Begum M, Das P, Faruk MO, Rahman S, Aktar S, Hasan MZ, ALmerab MM, Lathabhavan R, Al-Mamun F, Mamun MA.   +11 more
europepmc   +1 more source

Psilocybin‐assisted psychotherapy for methamphetamine use disorder: A pilot open‐label safety and feasibility study

Addiction, EarlyView.
Abstract Background & Aims There are few effective treatments for methamphetamine use disorder, despite increasing global demand. Here, we assessed the safety and feasibility of outpatient psilocybin‐assisted psychotherapy for methamphetamine use disorder. Design Single arm, open label pilot study.
Elizabeth Knock, Krista J. Siefried, Gill Bedi, Steven Albert, Richard O. Day, Nadine Ezard, Margaret Ross, Paul Liknaitzky, Jonathan Brett   +8 more
wiley   +1 more source